St Baldrick's Foundation funds Rhabdomyosarcoma Project

We are grateful to the team at the St Baldrick’s Foundation, their Board and their scientific advisors for funding our two-year research project, Overcoming Checkpoint Adaptation in Rhabdomyosarcoma by an Epigenetic Approach.  This study follows our July 2014 publication in Genes & Development highlighting the HDAC inhibitor, entinostat, as a drug that can turn off the Pax3:Foxo1 oncogene.